Source: Eur Respir Rev 2016; 25: 135-140
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Chelladurai Prakash, Seeger Werner, Pullamsetti Soni Savai. Epigenetic mechanisms in pulmonary arterial hypertension: the need for global perspectives. Eur Respir Rev 2016; 25: 135-140

Member's Comments

No comment yet.

Related content which might interest you: Partitioning of pulmonary vascular resistances in group 2 pulmonary hypertension: insightful suggestions for bridging haemodynamics to underlying mechanisms Source: Eur Respir J, 51 (5) 1800816; 10.1183/13993003.00816-2018 Year: 2018 Asthma and pulmonary arterial hypertension: Two phenotypes sharing a key underlying mechanism Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases Year: 2010 Novel therapeutic perspectives in pulmonary arterial hypertension Source: Eur Respir J 2003; 22: 193-194 Year: 2003 Novel techniques for advancing our understanding of pulmonary arterial hypertension Source: Eur Respir J, 53 (5) 1900556; 10.1183/13993003.00556-2019 Year: 2019 Novel insights into the pathogenesis of pulmonary arterial hypertension Source: Virtual Congress 2020 – Pulmonary vascular diseases Year: 2020 Epigenetic signature of right ventricular failure in pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 Future perspectives in pulmonary arterial hypertension Source: Eur Respir Rev 2016; 25: 381-389 Year: 2016 Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms Source: Eur Respir Rev, 30 (160) 200284; 10.1183/16000617.0284-2020 Year: 2021 Asthma and pulmonary arterial hypertension: do they share a key mechanism of pathogenesis? Source: Eur Respir J 2010; 35: 730-734 Year: 2010 Seeking the right targets: gene therapy advances in pulmonary arterial hypertension Source: Eur Respir J 2012; 39: 235-237 Year: 2012 Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed Source: Eur Respir J 2010; 36: 986-990 Year: 2010 The emerging role of epigenetics in pulmonary hypertension Source: Eur Respir J 2016; 48: 903-917 Year: 2016 The changing landscape of pulmonary arterial hypertension and implications for patient care Source: Eur Respir Rev 2014; 23: 450-457 Year: 2014 Pathogenesis of pulmonary arterial hypertension: lessons from cancer Source: Eur Respir Rev 2013; 22: 543-551 Year: 2013 The obesity paradox in pulmonary arterial hypertension: the Scottish perspective Source: ERJ Open Res, 5 (4) 00241-2019; 10.1183/23120541.00241-2019 Year: 2019 Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding Source: Eur Respir J 2013; 41: 462-468 Year: 2013 Identification of treatment goals in paediatric pulmonary arterial hypertension Source: Eur Respir J 2014; 44: 1616-1626 Year: 2014 Towards an understanding of pulmonary arterial hypertension (PAH): gene regulation patterns in pulmonary arterial resistance vessels of patients with PAH Source: Eur Respir J 2006; 28: Suppl. 50, 526s Year: 2006 Contemporary issues in pulmonary hypertension Source: Eur Respir Rev 2010 19: 266-271 Year: 2010